Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
04.04. | Neurocrine Biosciences Appoints Sanjay Keswani as Chief Medical Officer | ||
03.04. | Honeywell Unveils AI-Assisted Automation Platform for Life Sciences Manufacturing | ||
03.04. | Siemens to Acquire Boston-Based Dotmatics | ||
03.04. | Circio, Entos Enter Research Collaboration Focused on Circular RNA Delivery | ||
03.04. | Artis BioSolutions Emerges from Stealth, Acquires Landmark Bio | ||
03.04. | Navigo Proteins Enters R&D Collaboration with SCK CEN for Targeted Radiotheranostics | ||
03.04. | AGC Biologics Forms Cell and Gene Technologies Division | ||
02.04. | Bend Bioscience Adds Commercial Spray Drying & Granulation to Georgia Facility | ||
01.04. | Veeva Announces Research Site Clinical Trial Management System | ||
01.04. | Lonza Implements Streamlined Operating Model | ||
01.04. | Cellares' Cell Shuttle Receives FDA AMT Designation | ||
31.03. | DHL Group Acquires CRYOPDP from Cryoport | ||
31.03. | Sartorius Earns ISCC Plus Certification for Production Sites | ||
31.03. | ProBioGen Appoints Alfred Merz as CEO | ||
28.03. | Novo Nordisk Enters Exclusive License Agreement with Lexicon for LX9851 | ||
28.03. | Curium Pharma Acquires Monrol | ||
28.03. | Merck Seeks FDA Approval for Subcutaneous Pembrolizumab | ||
27.03. | National Resilience Bolsters Presence in Ohio | ||
27.03. | Linearis Opens New Lab in Quebec | ||
26.03. | Singota Solutions Opens New Facility in Balerna, Switzerland | ||
26.03. | Sanofi's Chlamydia Vaccine Candidate Granted Fast Track Designation by FDA | ||
26.03. | Theratechnologies Receives FDA Approval for EGRIFTA WR | ||
26.03. | GSK's Blujepa Approved by FDA for Treatment of uUTIs | ||
25.03. | Cytiva Expands Xcellerex X-Platform Portfolio | ||
25.03. | AstraZeneca to Invest $2.5B in New Global R&D Center in Beijing |